No attachments available.
PRECLINICAL SERVICES FOR BIOPHARMACEUTICAL PRODUCT DEVELOPMENT
Contact and place of performance
Tasha Lee
Elkridge, MD 21075
USA
IDIQ Contract Award Minimum $2,000 Maximum $30,000,000 Task Areas Awarded Task Area A - Product Development Planning and Evaluation Task Area B - Analytical Assay Development and Product Characterization Task Area C - Process Development and Related Activities Task Area D - CGMP Manufacture and Related Activities Task Area E - Regulatory Activities and Documentation
The National Institutes of Health issued an award notice for solicitation 75N93022R00004 to facilitate preclinical services for biopharmaceutical product development. This Indefinite Delivery, Indefinite Quantity contract carries a minimum value of $2,000 and a maximum potential value of $30,000,000. The work falls under NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC AN11 for HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH.
The scope of the award encompasses five distinct task areas: product development planning and evaluation, analytical assay development and product characterization, and process development. Additional requirements include CGMP manufacture and related activities as well as regulatory activities and documentation. Performance is centered in Elkridge, Maryland, with Tasha Lee serving as the point of contact. The notice was published and last updated on September 27, 2023.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.